Flameon
2021-06-30
Good news
Moderna’s Covid Shot Produces Antibodies Against Delta Variant
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
2
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":153113373,"tweetId":"153113373","gmtCreate":1625013180392,"gmtModify":1631893827282,"author":{"id":3562566709596645,"idStr":"3562566709596645","authorId":3562566709596645,"authorIdStr":"3562566709596645","name":"Flameon","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Good news</p></body></html>","htmlText":"<html><head></head><body><p>Good news</p></body></html>","text":"Good news","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/153113373","repostId":1176223224,"repostType":4,"repost":{"id":"1176223224","pubTimestamp":1625011026,"share":"https://www.laohu8.com/m/news/1176223224?lang=&edition=full","pubTime":"2021-06-30 07:57","market":"us","language":"en","title":"Moderna’s Covid Shot Produces Antibodies Against Delta Variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1176223224","media":"Bloomberg","summary":"Moderna Inc.said its vaccine produced protective antibodies against the delta variant spreading in t","content":"<p>Moderna Inc.said its vaccine produced protective antibodies against the delta variant spreading in the U.S. and many other parts of the world.</p>\n<p>Moderna researchers tested blood samples from eight people for antibodies against versions of the spike protein from different coronavirus variants, including delta, which emerged in India. The vaccine “produced neutralizing titers against all variants tested,” the company said in astatement. The results were released on the pre-print serverbioRxiv.</p>\n<p>The protective proteins are called neutralizing antibodies because they’re capable of preventing the virus from entering cells. Compared to the quantity of antibodies produced against the main version of the virus, neutralizing antibody levels against the delta variant were reduced by 2.1-fold.</p>\n<p>Shares of Moderna gained 5.9% at 10:24 a.m. in New York.</p>\n<p>Antibody levels were reduced by 4.2-fold against the eta strain first found Nigeria, and by eight-fold against a new variant identified in Angola called A.VOI.V2.</p>\n<p>High Enough</p>\n<p>The lab-based study did not directly measure vaccine effectiveness. Although reduced, the neutralizing antibody levels are still thought to be high enough to prevent disease, as the messenger RNA vaccine generates a strong immune reaction that creates a surplus of antibodies against the original strain.</p>\n<p>“We remain committed to studying emerging variants, generating data and sharing it as it becomes available. These new data are encouraging and reinforce our belief that the Moderna Covid-19 vaccine should remain protective against newly detected variants,” Moderna CEO Stephane Bancel said in the statement.</p>\n<p>Moderna earlier published research showing its vaccine produces neutralizing antibodies against the alpha, beta, and gamma variants that emerged in different regions.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna’s Covid Shot Produces Antibodies Against Delta Variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna’s Covid Shot Produces Antibodies Against Delta Variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-30 07:57 GMT+8 <a href=https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-produces-antibodies-against-delta-variant><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc.said its vaccine produced protective antibodies against the delta variant spreading in the U.S. and many other parts of the world.\nModerna researchers tested blood samples from eight ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-produces-antibodies-against-delta-variant\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-produces-antibodies-against-delta-variant","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176223224","content_text":"Moderna Inc.said its vaccine produced protective antibodies against the delta variant spreading in the U.S. and many other parts of the world.\nModerna researchers tested blood samples from eight people for antibodies against versions of the spike protein from different coronavirus variants, including delta, which emerged in India. The vaccine “produced neutralizing titers against all variants tested,” the company said in astatement. The results were released on the pre-print serverbioRxiv.\nThe protective proteins are called neutralizing antibodies because they’re capable of preventing the virus from entering cells. Compared to the quantity of antibodies produced against the main version of the virus, neutralizing antibody levels against the delta variant were reduced by 2.1-fold.\nShares of Moderna gained 5.9% at 10:24 a.m. in New York.\nAntibody levels were reduced by 4.2-fold against the eta strain first found Nigeria, and by eight-fold against a new variant identified in Angola called A.VOI.V2.\nHigh Enough\nThe lab-based study did not directly measure vaccine effectiveness. Although reduced, the neutralizing antibody levels are still thought to be high enough to prevent disease, as the messenger RNA vaccine generates a strong immune reaction that creates a surplus of antibodies against the original strain.\n“We remain committed to studying emerging variants, generating data and sharing it as it becomes available. These new data are encouraging and reinforce our belief that the Moderna Covid-19 vaccine should remain protective against newly detected variants,” Moderna CEO Stephane Bancel said in the statement.\nModerna earlier published research showing its vaccine produces neutralizing antibodies against the alpha, beta, and gamma variants that emerged in different regions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":38,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":8,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/153113373"}
精彩评论